Michelle Petri, M.D. is a Professor of Medicine at the Johns Hopkins University School of Medicine. She attended medical school at Harvard University and fulfilled her internal medicine residency at the Massachusetts General Hospital. In addition, she completed two fellowship programs at the University of California, San Francisco in allergy and immunology and rheumatology. Dr. Petri is the Director of the Hopkins Lupus Cohort, a longitudinal study of morbidity and mortality in systemic lupus erythematosus, and Co-Director of the Hopkins Lupus Pregnancy Center. Dr. Petri is rated as a Distinguished provider by MediFind in the treatment of Undifferentiated Connective Tissue Disease (UCTD). Her top areas of expertise are Lupus Nephritis, Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Tenotomy, and Osteotomy.

Dr. Homa Timlin is an assistant professor of medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include systemic lupus erythematosus, and lupus nephritis. Dr. Timlin serves on the faculty of the Johns Hopkins Consultative Rheumatology Clinic. A member of the Royal College of Physicians, Dr. Timlin earned her medical degree at Romania’s Universitatea de Medicana Si Farmacie Carol Davila. Upon completion of rheumatology fellowships, Oxford in the United Kingdom and an internal medicine residency in the United States, she joined the Johns Hopkins Lupus Center in 2011. After a one-year postdoctoral lupus fellowship under the mentorship of Dr. Michelle Petri, she finished her post-doctoral fellowship in rheumatology at Johns Hopkins. She also holds a master’s degree in clinical immunology (London University), MRCP diploma (Member of the Royal College of Physicians), Certificate of Completion of Specialty Training (CCST). Dr. Timlin has been an active educator who works with trainees at all levels, nationally and internationally, in the inpatient and outpatient settings. Presently, Dr. Timlin has established a retrospective cohort of several hundred patients with lupus and lupus nephritis, and site lead at the Johns Hopkins Bayview Medical Center. Dr. Timlin is the medical chair for the local chapter of Lupus Foundation of America (LFA) and the director of an IRB-approved prospective human diagnostic study using magnetic resonance imaging (MRI) to evaluate lupus nephritis. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Timlin is rated as an Advanced provider by MediFind in the treatment of Undifferentiated Connective Tissue Disease (UCTD). Her top areas of expertise are Lupus Nephritis, Systemic Lupus Erythematosus (SLE), Discoid Lupus Erythematosus (DLE), and Cutaneous Lupus Erythematosus (CLE).

Andrea Fava is a Rheumatologist in Baltimore, Maryland. Dr. Fava is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Connective Tissue Disease (UCTD). His top areas of expertise are Lupus Nephritis, Systemic Lupus Erythematosus (SLE), Scleroderma, and Systemic Sclerosis (SSc).

Dr. Wise is a pulmonary, critical care physician. He is an expert in the diagnosis and treatment of patients with obstructive lung disease, including those with asthma and COPD. He is a consultant for patients with scleroderma and interstitial lung disease. He has expertise in pulmonary physiology and lung function testing. Dr. Wise’s research focus is the conduct of multi-center clinical trials in airway diseases and related translational research. Dr. Wise is the co-director of the Pulmonary T32 Multi-disciplinary Training Program in Pulmonary Disease. Dr. Wise is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Connective Tissue Disease (UCTD). His top areas of expertise are Systemic Sclerosis (SSc), Interstitial Lung Disease, Acute Interstitial Pneumonia, and Sarcoidosis.

Dr. Wigley received his M.D. degree from the University of Florida College of Medicine. He completed an internship and residency at Johns Hopkins where he also trained in a postdoctoral fellowship program. Dr. Wigley is a physician-scientist whose specialty is Raynaud’s phenomenon and scleroderma. He founded The Johns Hopkins Scleroderma Center with Robert A. Wise, M.D., of the Johns Hopkins Division of Pulmonary Medicine. Dr. Wigley has been honored with two American College of Rheumatology awards over the past couple years. He received the ACR Distinguished Clinician Scholar Award in 2009 and the ACR Masters Award in 2011. Dr. Wigley is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Connective Tissue Disease (UCTD). His top areas of expertise are Scleroderma, Systemic Sclerosis (SSc), Raynaud Phenomenon, and Scleroma.

Dr. Ami Shah is an Associate Professor of Medicine and Director of the Division of Rheumatology at the Johns Hopkins University School of Medicine. Dr. Shah also serves as the Co-Director of the Johns Hopkins Scleroderma Center. Her areas of clinical expertise include rheumatology, particularly scleroderma and Raynaud's phenomenon. She is a graduate of the Massachusetts Institute of Technology and Johns Hopkins University School of Medicine. She completed her internal medicine residency training at Stanford University Hospital & Clinics and rheumatology post-doctoral fellowship at Johns Hopkins. During her fellowship training, she earned her Master of Health Science in Clinical Investigation at the Johns Hopkins Bloomberg School of Public Health. Dr. Shah’s clinical practice is focused on the broad spectrum of patients with scleroderma and related disorders, and her expertise includes management of complications such as Raynaud’s phenomenon, digital ischemia, pulmonary hypertension, cardiac dysfunction, myopathy, aggressive skin disease and concomitant cancer. Dr. Shah teaches post-doctoral fellows in her clinic about the evaluation and management of scleroderma. Dr. Shah’s research program has focused on the interface between cancer and autoimmunity in scleroderma, myositis and the newly emerging area of immune-related adverse events due to immune checkpoint inhibitor therapy. In highly collaborative studies, her group has published seminal observations linking cancer with the development of autoimmunity in scleroderma, with implications for cancer screening strategies in this population and the potential to shed insight into the pathogenesis of paraneoplastic rheumatic disease. In addition to her work in cancer and autoimmunity, Dr. Shah has an active research program in other clinical and therapeutic aspects of scleroderma, including early detection of cardiopulmonary complications and improving outcome measures and therapeutics for Raynaud's phenomenon. Dr. Shah also directs rheumatology precision medicine initiatives through the Johns Hopkins Individualized Health (inHealth) Initiative. The division’s program seeks to harness technological resources for comprehensive data collection and harmonization, strengthen novel data analytic approaches including defining unique patient subgroups, and accelerate the incorporation of discoveries into the delivery of clinical care. Dr. Shah has been a recipient of the ACR Research and Education Foundation Clinical Investigator Fellowship Award. In 2018, her research contributions were recognized at the 5th Systemic Sclerosis World Congress with receipt of the Edith Busch Prize for Young Investigators. In 2020, she was honored to receive the prestigious Henry Kunkel Young Investigator Award from the American College of Rheumatology. She is a member of the American College of Rheumatology. Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Connective Tissue Disease (UCTD). Her top areas of expertise are Scleroderma, Scleroma, Systemic Sclerosis (SSc), and Scleredema.

Dr. Julie Paik completed her medical school training at the George Washington University School of Medicine in Washington, DC. She then completed her residency and chief residency at UCLA-Cedars-Sinai/VA Medical Center in Los Angeles, California. She completed rheumatology fellowship at Johns Hopkins and joined the faculty in 2013. She currently sees patients at the Johns Hopkins Myositis Center and Scleroderma Center. Her research interests are in myositis and scleroderma or overlap myositis. She also has a special interest in novel therapeutics in refractory dermatomyositis. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Paik is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Connective Tissue Disease (UCTD). Her top areas of expertise are Dermatomyositis, Polymyositis, Myositis, and Scleroderma.

Dr. Christopher-Stine is the Co-Founder and Director of the Johns Hopkins Myositis Center. She is a Professor of Medicine and Neurology. She is a longstanding core faculty member of the Johns Hopkins University School of Medicine College Advisory Program and serves as the Co-Chair of the Johns Hopkins Institutional Review Board (IRB 5). Dr. Christopher-Stine graduated Cum Laude with a B.A. in chemistry from Franklin and Marshall College; was elected to Alpha Omega Alpha at Hahnemann University School of Medicine, where she received her MD degree, and she attained her Masters of Public Health degree from the Johns Hopkins Bloomberg School of Public Health. Her internship and residency training were completed at MCP Hahnemann University, where she also served as Chief Resident. She pursued her rheumatology fellowship training at Johns Hopkins. Dr. Christopher is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Connective Tissue Disease (UCTD). Her top areas of expertise are Myositis, Polymyositis, Dermatomyositis, and Inclusion Body Myositis.

Laura Hummers is an Associate Professor of Medicine in the Division of Rheumatology. She graduated from the University of Rochester School of Medicine and trained in internal medicine at Thomas Jefferson University. She then pursued her rheumatology fellowship at Johns Hopkins University and has since been on the faculty working at the Johns Hopkins Scleroderma Center since 2003 where she has been Co-Director of the Center. She received her ScM degree through the Graduate Training Program in Clinical Investigation from the Bloomberg School of Public Health in 2010. Dr. Hummers also serves as Clinical Director for the Division of Rheumatology. Dr. Hummers actively participates in a number of clinical trials and clinical investigations at the Scleroderma Center and has a particular interest in predictors of outcomes in scleroderma. She actively manages a large patient practice focused exclusively on scleroderma and related conditions at Johns Hopkins and actively helps to manage the Johns Hopkins Scleroderma Center longitudinal database. She also has specific expertise in other scleroderma-like conditions such as scleromyxedema, scleredema and eosinophilic fasciitis. Dr. Hummers is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Connective Tissue Disease (UCTD). Her top areas of expertise are Scleroderma, Systemic Sclerosis (SSc), Eosinophilic Fasciitis, and Scleroma.

Andrew Mammen is a Neuromusculoskeletal Medicine specialist and a Neurologist in Baltimore, Maryland. Dr. Mammen is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Connective Tissue Disease (UCTD). His top areas of expertise are Myositis, Polymyositis, Dermatomyositis, and Necrotizing Myopathy (NM).

Dr. Brit Adler is an Assistant Professor of Medicine in the Division of Rheumatology at Johns Hopkins University. She is building a career as a translational physician-scientist with a focus on Postural Orthostatic Tachycardia Syndrome (POTS) and infection-associated chronic illnesses. Her interest in this area emerged from her work in general rheumatology, where she frequently encountered patients with POTS, an often-overlooked and understudied condition. She is particularly interested in investigating the immune dysregulation underlying POTS, Long COVID, and Chronic Lyme Disease. By leveraging her prior experience in autoantibody discovery in rheumatic diseases, Dr. Adler aims to deepen our understanding of these conditions. In addition to her work in general rheumatology, Dr. Adler leads a dedicated POTS clinic and evaluates patients in the Hopkins Autonomic Lab, furthering her commitment to improving care for patients with autonomic disorders. She earned her medical degree from Case Western Reserve University in Cleveland, Ohio, and completed her residency in Internal Medicine at the Hospital of the University of Pennsylvania. Following this, she pursued a clinical and research fellowship in Rheumatology at Johns Hopkins. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Adler is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Connective Tissue Disease (UCTD). Her top areas of expertise are Dermatomyositis, Polymyositis, Myositis, and Inclusion Body Myositis.

Dr. Albayda is an Associate Professor of Medicine in the Division of Rheumatology. She is the Director of the Rheumatology Fellowship Program, as well as Director of the Musculoskeletal Ultrasound and Injection Clinic. Nationally, she is involved in MSK Ultrasound education and has expertise in arthritis and inflammatory myopathies. Her research focuses on imaging biomarkers in rheumatic diseases, developing muscle ultrasound, clinical phenotypes in myositis, as well as longitudinal care and therapeutics in inclusion body myositis. Dr. Albayda is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Connective Tissue Disease (UCTD). Her top areas of expertise are Dermatomyositis, Pallister-Killian Mosaic Syndrome, Temple Syndrome, and Inclusion Body Myositis.

Dr. Christopher A. Mecoli is an Associate Professor of Medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise is rheumatology. A physician-scientist, Dr. Mecoli serves on the faculty of Johns Hopkins Myositis Center and Johns Hopkins Scleroderma Center. He earned his M.D. from Rutgers New Jersey Medical School. He completed an internal medicine residency at the Hospital of the University of Pennsylvania and a rheumatology fellowship at Johns Hopkins. He also holds an M.H.S. in clinical investigation from the Johns Hopkins Bloomberg School of Public Health. Dr. Mecoli is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Connective Tissue Disease (UCTD). His top areas of expertise are Dermatomyositis, Myositis, Scleroderma, and Polymyositis.

Matthew Lammi, MD MSCR is an Associate Professor of Medicine and part of the Interstitial Lung Disease (ILD) Program. Dr. Lammi obtained his medical degree from Temple University School of Medicine and did his internal medicine, pulmonary, and critical care training at Temple University Hospital. He then joined the faculty at LSU in New Orleans, where he served as the Director of the Comprehensive Pulmonary Hypertension Center. He joined Johns Hopkins in 2023. He currently serves as the Associate Director of the Johns Hopkins Pulmonary Fibrosis Foundation Care Center and is the Associate Program Director for the Advanced Lung Disease Fellowship. His research focuses on the intersection between ILD and pulmonary hypertension, particularly in patients with systemic sclerosis. He is currently a co-Principal Investigator for a clinical trial of therapy for scleroderma associated pulmonary hypertension supported by the Department of Defense Peer Reviewed Medical Research Program. He is active in numerous societies and serves as the Chair of the Research Committee for the Pulmonary Hypertension Association. Dr. Lammi is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Connective Tissue Disease (UCTD). His top areas of expertise are Pulmonary Hypertension, Sarcoidosis, Systemic Sclerosis (SSc), Interstitial Lung Disease, and Lung Transplant.

Dr. Uzma Haque is an Assistant Professor of Medicine at the Arthritis Center at The Hopkins Bayview Medical Center, and is actively engaged in clinical care to patients with general rheumatic and musculoskeletal disorders. Dr. Haque is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Connective Tissue Disease (UCTD). Her top areas of expertise are Rheumatoid Arthritis (RA), Arthritis, Psoriatic Arthritis, and Psoriasis.

Melody Chung is a Rheumatologist in Baltimore, Maryland. Dr. Chung is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Connective Tissue Disease (UCTD). Her top areas of expertise are Systemic Sclerosis (SSc), Scleroderma, Myositis, and Dermatomyositis.

Dr. Grader-Beck is an Associate Professor of Clinical Medicine in the Rheumatology Division. Dr. Grader-Beck’s clinical expertise includes the diagnosis and treatment of Sjogren's syndrome as well as inflammatory arthritis. He has a specific interest in improving quality of patient care and clinical research using state of the art information technology. He is developing innovative ways in how clinicians and researchers can leverage electronic health record systems to deliver individualized patient care and precision medicine. Dr. Grader is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Connective Tissue Disease (UCTD). His top areas of expertise are Sjogren Syndrome, Rheumatoid Arthritis (RA), Interstitial Keratitis, and Dermatomyositis.

John Miller is a Rheumatologist in Baltimore, Maryland. Dr. Miller is rated as an Experienced provider by MediFind in the treatment of Undifferentiated Connective Tissue Disease (UCTD). His top areas of expertise are Microscopic Polyangiitis, Scleroderma, Rheumatoid Arthritis (RA), and Erythromelalgia.

George Stojan is a Rheumatologist in Baltimore, Maryland. Dr. Stojan is rated as an Advanced provider by MediFind in the treatment of Undifferentiated Connective Tissue Disease (UCTD). His top areas of expertise are Systemic Lupus Erythematosus (SLE), Undifferentiated Connective Tissue Disease (UCTD), Lupus Nephritis, and Rheumatoid Arthritis (RA).

Lanaya Smith is a Rheumatologist in Baltimore, Maryland. Dr. Smith is rated as an Advanced provider by MediFind in the treatment of Undifferentiated Connective Tissue Disease (UCTD). Her top areas of expertise are Mixed Connective Tissue Disease, MASS Phenotype, IgG4-Related Disease, MAGIC Syndrome, and Tissue Biopsy. Dr. Smith is currently accepting new patients.